Search Results
May 12, 2026, 09:00 ET Restaurant365 Introduces R365 AI, the Only Intelligence Engine Built on the Full Restaurant P&L
platform, today announced R365 AI, an intelligence engine designed to help operators make faster decisions, reduce manual work, and improve profitability across their business. Restaurant365 uniquely connects accounting, inventory, labor, scheduling, and POS data in one system, giving R365 AI the complete operational
More news about: Restaurant365
May 12, 2026, 09:00 ET Constellation Research Unveils 2026-2027 BT150: The Executives Redefining Digital Leadership
results. "The BT150 has evolved into one of the most influential networks of senior technology and business leaders shaping the modern enterprise," said R "Ray" Wang, founder and CEO at Constellation Research. "Today's landscape is defined by AI disruption, and every leader faces margin compression, exponential
More news about: Constellation Research
May 12, 2026, 09:00 ET Norm Ai Launches Compliance Agent for Microsoft 365 Copilot
legal work. Norm Ai has raised more than $140 million from Blackstone, Bain Capital, Vanguard, Citi, New York Life, TIAA, Coatue, Craft Ventures, Henry R. Kravis, and Marc Benioff.For more information, visit
More news about: Norm Ai
May 12, 2026, 09:00 ET Porton Advanced Stem Cell Exosomes Granted INCI Status, Advancing into Global Cosmetic Ingredient Market
including HEK293, MSC, K562, and iPSC.Scalable and Robust Processes: Scalable from 2L to 50L bioreactors, enabling seamless transition from R&D to commercial production.High Yield: Final exosome product concentration ≥ 1E+11 particles/mL.Rapid Delivery: GMP-grade exosomes
More news about: Porton Advanced
May 12, 2026, 09:00 ET Vella Bioscience Launches Ebbtide™, A Science-Driven Vaginal Insert Designed to Address the Source of Menstrual Discomfort
Advisory Board. "Ebbtide is different because it works at the physiological source of cramping and tension. The underlying science - developed by Vella's R&D team - focuses on reducing uterine contractility through a novel combination of CBD and CBDA. That scientific rigor translates into real-world impact:
More news about: Vella Bioscience
May 12, 2026, 08:44 ET More Than Half of First-Time C-Suite Executives Fail Within 18 Months -- New Book Exposes the Preparation Gap Costing Organizations Billions
www.coachsulting.global.MEDIA CONTACT:Flo JacobsAndrea R. Nicholas, LLCPhone: 512-650-8841Email: [email protected]:
More news about: Andrea Nicholas, LLC
May 12, 2026, 08:34 ET ACS and Siemens Host Two-Day Technical Training on Durability, Vibration Control, and Simcenter Testlab Neo
designed and engineered to work together. We combine our knowledge of building design and construction with expertise and understanding of equipment, R&D and production test, process systems, automation, data acquisition, and controls for industry leaders who require high-performance systems. ACS is
More news about: ACS
May 12, 2026, 08:30 ET Insilico Medicine and Ribo Enter Strategic Collaboration Agreement: Leveraging AI Platform and Automated Lab for End-to-End Empowerment of RNA Interference and Oligonucleotide Therapeutics Development
service cooperation, combining the end-to-end R&D capabilities of Insilico's proprietary Pharma.AI platform with Ribo's profound expertise in oligonucleotide therapeutics development, aiming for comprehensive efficiency boost in the oligonucleotide drug R&D cycle. "We are now in a new era of
More news about: Insilico Medicine
May 12, 2026, 08:30 ET Emiltatug Ledadotin (Emi-Le) Granted Breakthrough Therapy Designation by the U.S. FDA for Adenoid Cystic Carcinoma (ACC)
a long-term vision, free of influence from fiduciary responsibilities.Servier invests close to 20% of revenue from brand-name medicines in R&D each year. Servier aspires to advance more targeted therapies by identifying mutations and understanding how these mutations impact cancer and its
More news about: Servier Pharmaceuticals
May 12, 2026, 08:30 ET Ribo Announces Strategic Collaboration with Insilico Medicine to Accelerate siRNA Drug Development Driven by AI
upgraded strategic collaboration leverages Ribo's profound industrial expertise and leading development capabilities in siRNA technology and drug R&D, together with Insilico Medicine's end-to-end AI-powered drug discovery platform. It delivers full complementary strengths and in-depth synergy, accelerating
More news about: Suzhou Ribo Life Science Co., Ltd.
May 12, 2026, 08:30 ET Valor Econômico to Host Brazil-USA Summit in New York, Presented by XP Inc.
bilateral economic relations.Confirmed speakers include Eduardo Leite, Governor of the State of Rio Grande do Sul; Bernie Moreno, U.S. Senator (R-Ohio); Pablo Goldberg, Head of Research at BlackRock; Alexandre Bettamio, Chair of Investment Banking at Bank of America; José Berenguer, CEO of Banco XP;
More news about: XP Inc.
May 12, 2026, 08:30 ET PTC Onshape Introduces Direct Altium Integration to Streamline ECAD-MCAD Collaboration
Nikolay Ponomarenko, Vice President of Altium R&D. "In a complex, fast-paced industry, cloud data enables engineers to collaborate in real-time within a unified workflow across design domains. This
More news about: PTC Inc.
May 12, 2026, 08:30 ET Found Industries and ARES Strategic Mining Sign MOU to Advance Domestic Gallium, Germanium and Fluorspar Recovery from Utah's Lost Sheep Mine
resilience. Through its Found Metals division, the company is developing a vertically integrated critical metals platform that spans foundational R&D, process development, electrochemical system design, engineering, pilot deployment, and commercial project development. Found Metals is focused on
More news about: Found Industries
May 12, 2026, 08:28 ET DrugBank Launches Advisory Board to Guide AI Adoption in Biopharma
avoiding costly late-stage failures.Susan Roberts, a member of DrugBank's Board of Directors and Vice President of Research, PharmSci, and PDT R&D Data, Digital, and Technology at Takeda Pharmaceuticals, will serve as Lead of the Advisory Board, translating board priorities into focused areas
More news about: DrugBank
May 12, 2026, 08:03 ET Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief Medical Officer
immune biology.Final Phase 2 Results to Be Presented at EHA2026The open-label, single-arm Phase 2 trial enrolled 37 adults with IPSS-R very low- to intermediate-risk MDS (score ≤4.5) who had symptomatic anemia or red blood cell (RBC) transfusion dependence and were refractory to, intolerant
More news about: Halia Therapeutics
May 12, 2026, 08:00 ET Splat Launches Midnight Black Cherry--The Viral Cherry Cola Hair Trend, Now with Visible Payoff on Brunettes (No Bleach Required)
color correction and transformation to effortless gray coverage, empowering consumers with confidence, creativity, and control. Vertically integrated R&D, formulation, and manufacturing bring ideas to market with speed, precision, and consistent quality. Vegan-certified, cruelty-free, and proudly made
More news about: DEVELOPLUS, INC.
May 12, 2026, 07:56 ET Teleste and Vecima Launch Open, Interoperable DAA Solution for European Operators
https://news.cision.com/teleste-corporation/r/teleste-and-vecima-launch-open--interoperable-daa-solution-for-european-operators,c4347419
More news about: Teleste Corporation
May 12, 2026, 07:52 ET Teleste and Vecima Launch Open, Interoperable DAA Solution for European Operators
https://news.cision.com/teleste-corporation/r/teleste-and-vecima-launch-open--interoperable-daa-solution-for-european-operators,c4347419
More news about: Teleste Corporation
May 12, 2026, 07:50 ET Johnson Controls amplía su presencia europea en Dinamarca
refrigeración desde que Thomas Sabroe fundó la empresa aquí en 1897», declaró Benthe Klokkerholm, vicepresidente de Operaciones de Fabricación de HVAC/R para EMEA. «Con esta expansión, Aarhus consolida aún más su posición como centro de excelencia en tecnología de calefacción urbana, aportando valor a
More news about: Johnson Controls International plc
May 12, 2026, 07:30 ET TuHURA Biosciences to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
addition to its innate immune agonist product candidates, TuHURA is developing TBS-2025, a VISTA inhibiting mAb moving into Phase 1b/2 in mutNPM1 r/r AML, a molecularly defined subgroup of patients with AML. In addition, TuHURA is leveraging its Delta Opioid Receptor technology to develop first-in-class,
More news about: TuHURA Biosciences, Inc.
May 12, 2026, 07:30 ET Johnson Controls udvider sin tilstedeværelse i Europa med åbningen af nye ingeniør-, produktions- og kundecentre i Danmark
varme og køling, siden Thomas Sabroe grundlagde virksomheden her i 1897,« sagde Benthe Klokkerholm, vicepræsident for produktionsdrift inden for HVAC/R i EMEA. »Med denne udvidelse styrker Aarhus yderligere sin rolle som et kompetencecenter inden for fjernvarme, der skaber værdi for kunder i hele Europa
More news about: Johnson Controls International plc
May 12, 2026, 07:01 ET Acurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update
the quarter, the Company raised a total of approximately $3.1 million of gross proceeds through purchases under the Equity Line of Credit.R&D Expenses:Research and development expenses for the three months ended March 31, 2026 were $0.3 million compared to $0.6 million for the
More news about: Acurx Pharmaceuticals, Inc.
May 12, 2026, 07:00 ET New Data Show Gaps in Antiviral Pipeline Against High-Risk Viral Threats
transmission, and mortality rates.A significant increase in R&D investment and activity is needed to fill the pipeline gaps. Government and philanthropic funding play a critical role in helping to de-risk early-stage R&D, which in turn can attract the private investment needed in advance
More news about: INTREPID Alliance
May 12, 2026, 07:00 ET New Data Show Gaps in Antiviral Pipeline Against High-Risk Viral Threats
transmission, and mortality rates.A significant increase in R&D investment and activity is needed to fill the pipeline gaps. Government and philanthropic funding play a critical role in helping to de-risk early-stage R&D, which in turn can attract the private investment needed in advance
More news about: INTREPID Alliance